Merit Medical Systems, Inc. MMSI
Set alert
As of Nov 2, 11:41 AM ET
- YTD
- -4.25%
- 1 year
- -3.59%
- Open
- 86.26
- Prev close
- 86.24
- Mkt cap
- 5.07B
- Vol
- 319.29K
- Avg vol
- 755.20K
- EPS
- 2.67
- P/E
- 31.67
- Div yield
- 0.00%
More statistics
- Low
- 83.72
- High
- 86.34
- Forward P/E
- 18.55
- Beta
- 0.51
- Short ratio
- 6.23
- Inst. own
- 108.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 88.68
- 200-d avg
- 76.92
- 1y target
- 100.67
2Y chart
Events in this range
- Oct 30, 2025Earnings: 0.92; estimate 0.82; surprise 12.2%
- Feb 24, 2026Earnings: 1.04; estimate 0.96; surprise 8.33%
- Apr 30, 2026Earnings: 0.94; estimate 0.84; surprise 11.9%
- Jul 30, 2026Earnings: 1.19; estimate 0.959; surprise 24.09%
- Aug 13, 2026Rating: B of A Securities · Neutral → Neutral
- Sep 29, 2026Rating: Needham · Buy → Buy
- Oct 27, 2026Rating: Freedom Capital Markets · — → Hold
- Oct 29, 2026Earnings: 1.12; estimate 1.04; surprise 7.69%
- Oct 30, 2026Rating: BTIG · Buy → Buy
- Oct 30, 2026Rating: Needham · Buy → Buy
- Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (77)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 21, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 25, 2026 | 7 months ago |
| RSI: Oversold | Mar 20, 2026 | 7 months ago |
| RSI: Oversold | Mar 18, 2026 | 7 months ago |
| RSI: Oversold | Mar 16, 2026 | 7 months ago |
| RSI: Oversold | Mar 6, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 10 months ago |
| RSI: Overbought | Jan 6, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| SMA: Bearish | Dec 4, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 28, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bullish | Nov 20, 2025 | 11 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Oct 31, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 17, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 16, 2025 | 1 year ago |
| RSI: Oversold | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 26, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| SMA: Bullish | Mar 5, 2025 | 1 year ago |
| SMA: Bearish | Mar 4, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 12, 2025 | 1 year ago |
| RSI: Overbought | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 14, 2025 | 1 year ago |
Key statistics
- Market cap
- 5.15B
- Enterprise value
- 5.95B
- Trailing P/E
- 35.49
- Forward P/E
- 18.55
- PEG ratio
- 1.69
- Price / sales
- 3.26
- Price / book
- 3.24
- EPS (TTM)
- 2.43
- Beta
- 0.51
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 9.22%
- Revenue (TTM)
- 1.58B
- Revenue growth
- 9.50%
- Free cash flow
- 173.90M
- Total cash
- 448.70M
- Total debt
- 820.12M
- Return on equity
- 9.19%
- Shares outstanding
- 59.71M
- Short % of float
- 8.59%
- 50-day average
- 88.68
- 200-day average
- 76.92
Analyst view
Consensus: buy
- Target (low)
- 83.00
- Target (mean)
- 100.67
- Target (high)
- 123.00
- Strong buy5
- Buy4
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 1.13.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 1.12 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.04 | 1.12 | +0.08 | +7.69% |
| Jul 30, 2026 | Jun 30, 2026 | 0.959 | 1.19 | +0.23 | +24.09% |
| Apr 30, 2026 | Mar 31, 2026 | 0.84 | 0.94 | +0.10 | +11.90% |
| Feb 24, 2026 | Dec 31, 2025 | 0.96 | 1.04 | +0.08 | +8.33% |
| Oct 30, 2025 | Sep 30, 2025 | 0.82 | 0.92 | +0.10 | +12.20% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Needham | main | Buy | Buy |
| Oct 30, 2026 | BTIG | main | Buy | Buy |
| Oct 27, 2026 | Freedom Capital Markets | init | — | Hold |
| Sep 29, 2026 | Needham | reit | Buy | Buy |
| Aug 13, 2026 | B of A Securities | main | Neutral | Neutral |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- merit.com
News
- Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121
- JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $110
- Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $92
- These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
- These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
- Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $106
- BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $110
- Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
- Merit Medical Systems Q3 Earnings Call Highlights
- Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates
Your note
Sign in to keep a note on MMSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARONSON MARTHA GOLDBERG | Chief Executive Officer | Purchase | May 5, 2026 | 49,792 |
| CARPENTER LONNY J | Director | Stock Award(Grant) | May 17, 2026 | 20,824 |
| GUNDERSON THOMAS JAMES | Director | Conversion of Exercise of derivative security | May 19, 2026 | 60,741 |
| LAMPROPOULOS FRED P | Officer and Director | Sale | Nov 24, 2025 | 1,126,460 |
| LLOYD BRIAN G | Officer | Stock Gift | Jun 4, 2026 | 62,132 |
| MILLNER F ANN | Director | Stock Award(Grant) | May 17, 2026 | 38,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.85% | 9,464,542 | 816.32M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.82% | 3,473,833 | 299.62M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.34% | 2,590,454 | 223.43M | Jun 29, 2026 |
| State Street Corporation | 4.14% | 2,474,512 | 213.43M | Jun 29, 2026 |
| Conestoga Capital Advisors, LLC | 3.32% | 1,979,790 | 170.76M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.72% | 1,625,950 | 140.24M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.96% | 3,556,402 | 306.74M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.02% | 1,802,360 | 155.45M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.59% | 1,543,773 | 133.15M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.58% | 1,542,648 | 133.05M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.18% | 1,299,239 | 112.06M | Jun 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 1.60% | 958,075 | 82.63M | Jun 29, 2026 |